Published 60-Day Notice

4-9-18.Agency IC Activities; Data Elements for Student Enrollment in Bureau-Funded Schools.pdf

Data Elements for Student Enrollment in Bureau - funded Schools

Published 60-Day Notice

OMB: 1076-0122

⚠️ Notice: This form may be outdated. More recent filings and information on OMB 1076-0122 can be found here:

Document [pdf]

Download: pdf | pdf

15174

Federal Register / Vol. 83, No. 68 / Monday, April 9, 2018 / Notices

sradovich on DSK3GMQ082PROD with NOTICES

Stat. 543, section 3, as amended. The
regulations art 25 CFR 226 implement
that statute by specifying what
information a lessee must provide
related to drilling, development, and
production of oil and gas on Osage
reservation land. The oil, gas, and land
are assets that the United States holds
in trust or restricted status for Indian
beneficiaries. The information
collections in 25 CFR 226 are necessary
to ensure that the beneficial owners of
the mineral rights are provided the
royalties due them, ensure that the oil
and gas trust assets are protected, and to
ensure that the surface estate assets are
protected.
Title of Collection: Leasing of Osage
Reservation lands for Oil and Gas
Mining.
OMB Control Number: 1076–0180.
Form Number: N/A.
Type of Review: Revision of a
currently approved collection.
Respondents/Affected Public:
Individual Indians, businesses, and
Tribal authorities.
Total Estimated Number of Annual
Respondents: 965.
Total Estimated Number of Annual
Responses: 14,436.
Estimated Completion Time per
Response: Varies from 15 minutes to
eight hours.
Total Estimated Number of Annual
Burden Hours: 21,954.
Respondent’s Obligation: Required to
Obtain a Benefit.
Frequency of Collection: Varies from
yearly to monthly.
Total Estimated Annual Nonhour
Burden Cost: $496.
An agency may not conduct or
sponsor and a person is not required to
respond to a collection of information
unless it displays a currently valid OMB
control number.
The authority for this action is the
Paperwork Reduction Act of 1995 (44
U.S.C. 3501 et seq.).
Dated: April 3, 2018.
Elizabeth K. Appel,
Director, Office of Regulatory Affairs and
Collaborative Action—Indian Affairs.
[FR Doc. 2018–07121 Filed 4–6–18; 8:45 am]
BILLING CODE 4337–15–P

VerDate Sep<11>2014

18:06 Apr 06, 2018

Jkt 244001

DEPARTMENT OF THE INTERIOR
Bureau of Indian Affairs
[189A2100DD/AAKC001030/
A0A501010.999900 253G; OMB Control
Number 1076–0122]

Agency Information Collection
Activities; Data Elements for Student
Enrollment in Bureau-Funded Schools
Bureau of Indian Affairs,
Interior.
ACTION: Notice of information collection;
request for comment.
AGENCY:

In accordance with the
Paperwork Reduction Act of 1995, we,
the Bureau of Indian Education (BIE) are
proposing to renew an information
collection.

SUMMARY:

Interested persons are invited to
submit comments on or before June 8,
2018.
ADDRESSES: Send your comments on
this information collection request (ICR)
by mail to: Dr. Joe Herrin, Bureau of
Indian Education, 1849 C Street NW,
MS–3620–MIB, Washington, DC 20240;
facsimile: (202) 208–7658; email:
[email protected]. Please reference
OMB Control Number 1076–0122 in the
subject line of your comments.
FOR FURTHER INFORMATION CONTACT: To
request additional information about
this ICR, contact Dr. Joe Herrin, phone:
(202) 208–7658.
SUPPLEMENTARY INFORMATION: In
accordance with the Paperwork
Reduction Act of 1995, we provide the
general public and other Federal
agencies with an opportunity to
comment on new, proposed, revised,
and continuing collections of
information. This helps us assess the
impact of our information collection
requirements and minimize the public’s
reporting burden. It also helps the
public understand our information
collection requirements and provide the
requested data in the desired format.
We are soliciting comments on the
proposed ICR that is described below.
We are especially interested in public
comment addressing the following
issues: (1) Is the collection necessary to
the proper functions of the BIE; (2) will
this information be processed and used
in a timely manner; (3) is the estimate
of burden accurate; (4) how might the
BIE enhance the quality, utility, and
clarity of the information to be
collected; and (5) how might the BIE
minimize the burden of this collection
on the respondents, including through
the use of information technology.
Comments that you submit in
response to this notice are a matter of
DATES:

PO 00000

Frm 00050

Fmt 4703

Sfmt 4703

public record. We will include or
summarize each comment in our request
to OMB to approve this ICR. Before
including your address, phone number,
email address, or other personal
identifying information in your
comment, you should be aware that
your entire comment—including your
personal identifying information—may
be made publicly available at any time.
While you can ask us in your comment
to withhold your personal identifying
information from public review, we
cannot guarantee that we will be able to
do so.
Abstract: The BIE is requesting
renewal of OMB approval for the
admission forms for the Student
Enrollment Application in Bureaufunded Schools. School registrars
collect information on this form to
determine the student’s eligibility for
enrollment in a Bureau-funded school,
and if eligible, is shared with
appropriate school officials to identify
the student’s base and supplemental
educational and/or residential program
needs. The BIE compiles the
information into a national database to
facilitate budget requests and the
allocation of congressionally
appropriated funds.
Title of Collection: Data Elements for
Student Enrollment in Bureau-funded
Schools.
OMB Control Number: 1076–0122.
Form Number: None.
Type of Review: Extension of a
currently approved collection.
Respondents/Affected Public:
Contract and Grant schools, and Bureaufunded schools.
Total Estimated Number of Annual
Respondents: 47,000 per year, on
average.
Total Estimated Number of Annual
Responses: 47,000 per year, on average.
Estimated Completion Time per
Response: 15 minutes.
Total Estimated Number of Annual
Burden Hours: 11,750 hours.
Respondent’s Obligation: Required to
Obtain a Benefit.
Frequency of Collection: Once per
year.
Total Estimated Annual Nonhour
Burden Cost: $0.
An agency may not conduct or
sponsor and a person is not required to
respond to a collection of information
unless it displays a currently valid OMB
control number.
The authority for this action is the
Paperwork Reduction Act of 1995 (44
U.S.C. 3501 et seq.).

E:\FR\FM\09APN1.SGM

09APN1

15175

Federal Register / Vol. 83, No. 68 / Monday, April 9, 2018 / Notices
Dated: April 3, 2018.
Elizabeth K. Appel,
Director, Office of Regulatory Affairs and
Collaborative Action—Indian Affairs.
[FR Doc. 2018–07122 Filed 4–6–18; 8:45 am]
BILLING CODE 4337–15–P

DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—UHD Alliance, Inc.
Notice is hereby given that, on March
8, 2018, pursuant to Section 6(a) of the
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), UHD Alliance, Inc.
(‘‘UHD Alliance’’) filed written
notifications simultaneously with the
Attorney General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, Google, Inc., Mountain
View, CA; Teledyne LeCroy, Elgin, IL;
and Synaptics, San Jose, CA, have been
added as parties to this venture.
Also, HDAnywhere Ltd., Malvern,
UNITED KINGDOM; Quantum Data,
Inc., Elgin, IL; and Sky UK Ltd.,
Isleworth, UNITED KINGDOM, have
withdrawn as parties to this venture.
In addition, the following members
have changed their names: Koninklijke
Philips N.V. to Philips International
B.V.–IP&S, Eindhoven,
NETHERLANDS; and DTS, Inc., to
Xperi Corporation, Calabasas, CA.
No other changes have been made in
either the membership or planned

activity of the group research project.
Membership in this group research
project remains open, and UHD Alliance
intends to file additional written
notifications disclosing all changes in
membership.
On June 17, 2015, UHD Alliance filed
its original notification pursuant to
Section 6(a) of the Act. The Department
of Justice published a notice in the
Federal Register pursuant to Section
6(b) of the Act on July 17, 2015 (80 FR
42537).
The last notification was filed with
the Department on December 15, 2017.
A notice was published in the Federal
Register pursuant to Section 6(b) of the
Act on February 12, 2018 (83 FR 6051).
Patricia A. Brink,
Director of Civil Enforcement, Antitrust
Division.
[FR Doc. 2018–07129 Filed 4–6–18; 8:45 am]
BILLING CODE 4410–11–P

DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]

Importer of Controlled Substances
Application: United States
ACTION:

Notice of application.

Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before May 9, 2018. Such persons
may also file a written request for a
hearing on the application on or before
May 9, 2018.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
DATES:

Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All request for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/LJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DRW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
delegated to the Assistant Administrator
of the DEA Diversion Control Division
(‘‘Assistant Administrator’’) pursuant to
section 7 of 28 CFR part 0, appendix to
subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on March
1, 2018, United States Pharmacopeial
Convention, 12601 Twinbrook Parkway,
Rockville, MD, 20852 applied to be
registered as an importer of the
following basic classes of controlled
substances:

SUPPLEMENTARY INFORMATION:

sradovich on DSK3GMQ082PROD with NOTICES

Controlled substance

Drug code

Cathinone ........................................................................................................................................................................
Methaqualone ..................................................................................................................................................................
Lysergic acid diethylamide ..............................................................................................................................................
4-Methyl-2,5-dimethoxyamphetamine .............................................................................................................................
4-Methoxyamphetamine ..................................................................................................................................................
Codeine-N-oxide ..............................................................................................................................................................
Difenoxin ..........................................................................................................................................................................
Heroin ..............................................................................................................................................................................
Morphine-N-oxide ............................................................................................................................................................
Norlevorphanol ................................................................................................................................................................
Methamphetamine ...........................................................................................................................................................
Phenmetrazine .................................................................................................................................................................
Methylphenidate ..............................................................................................................................................................
Amobarbital ......................................................................................................................................................................
Pentobarbital ....................................................................................................................................................................
Secobarbital .....................................................................................................................................................................
Glutethimide .....................................................................................................................................................................
Phencyclidine ...................................................................................................................................................................
Phenylacetone .................................................................................................................................................................
Alphaprodine ....................................................................................................................................................................
Anileridine ........................................................................................................................................................................
Cocaine ............................................................................................................................................................................